US Patent Issued to TOHOKU UNIVERSITY on Aug. 18 for "Marker of epithelial-mesenchymal transition in pancreatic cancer" (Japanese Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,709,776, issued on Aug. 18, was assigned to TOHOKU UNIVERSITY (Miyagi, Japan).

"Marker of epithelial-mesenchymal transition in pancreatic cancer" was invented by Kazuhiko Igarashi (Miyagi, Japan), Mitsuyo Matsumoto (Miyagi, Japan), Masaki Sato (Miyagi, Japan) and Hironari Nishizawa (Miyagi, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "In order to elucidate the mechanism of malignant alteration of pancreatic cancer caused by BACH1, changes in the gene expression depending on the expression level of BACH1 in the pancreatic cancer cell line were clarified by RNA sequencing. As a result of experiments on in vitro migration ability and invasion abili...